| IL-17 in cutaneous lupus erythematosus C Tanasescu, E Balanescu, P Balanescu, R Olteanu, C Badea, ... European journal of internal medicine 21 (3), 202-207, 2010 | 118 | 2010 |
| Pharmacological treatment in calcinosis cutis associated with connective-tissue diseases A Dima, P Balanescu, C Baicus Rom J Intern Med 52 (2), 55-67, 2014 | 44 | 2014 |
| Th17 and IL-17 immunity in chronic hepatitis C infection P Bălănescu, A Lădaru, T Voiosu, A Nicolau, M Ene, E Bălănescu Rom J Intern Med 50 (1), 13-8, 2012 | 41 | 2012 |
| IL-17, IL-6 and IFN-γ in systemic sclerosis patients P Bălănescu, A Lădaru, E Bălănescu, A Nicolau, C Băicuş, GA Dan Romanian Journal of Internal Medicine 53 (1), 46-51, 2015 | 38 | 2015 |
| Serum endocan levels are increased in patients with inflammatory bowel disease T Voiosu, P Bălănescu, A Benguş, A Voiosu, CR Baicuş, M Barbu, ... Clinical laboratory 60 (3), 505-510, 2014 | 38 | 2014 |
| Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study T Voiosu, A Benguş, R Dinu, AM Voiosu, P Bălănescu, C Băicuş, ... J Gastrointestin Liver Dis 23 (3), 273-278, 2014 | 36 | 2014 |
| Endocan, novel potential biomarker for systemic sclerosis: results of a pilot study P Bălănescu, A Lădaru, E Bălănescu, T Voiosu, C Băicuş, GA Dan Journal of clinical laboratory analysis 30 (5), 368-373, 2016 | 30 | 2016 |
| Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review A Lădaru, P Bălănescu, M Stan, I Codreanu, IA Anca Biomarkers 21 (2), 102-114, 2016 | 28 | 2016 |
| Annexin A5 as independent predictive biomarker for subclinical atherosclerosis and endothelial dysfunction in systemic lupus erythematosus patients. P Valer, B Paul, B Eugenia, B Camelia Clinical laboratory 59 (3-4), 359-367, 2013 | 28 | 2013 |
| Measuring trainee competence in performing endoscopic retrograde cholangiopancreatography: A systematic review of the literature T Voiosu, P Bălănescu, A Voiosu, A Benguş, C Preda, DS Umans, ... United European Gastroenterology Journal 7 (2), 239-249, 2019 | 24 | 2019 |
| IL-17 and Th17 cells in systemic sclerosis: a comprehensive review P Bălănescu, E Bălănescu, A Bălănescu Romanian Journal of Internal Medicine 55 (4), 198-204, 2017 | 23 | 2017 |
| Clinical significance of serum and urinary interleukin-6 in systemic lupus erythematosus patients A Dima, C Jurcut, P Balanescu, E Balanescu, C Badea, S Caraiola, I Miler, ... The Egyptian Rheumatologist 39 (1), 1-6, 2017 | 22 | 2017 |
| T helper 17 cell population in lupus erythematosus P Bălănescu, E Bălănescu, C Tănăsescu, A Nicolau, R Tănăsescu, ... Rom J Intern Med 48 (3), 255-9, 2010 | 21 | 2010 |
| Original clinical experience and approach to treatment study with interleukine 12/23 inhibitor in moderate-to-severe psoriasis patients R Olteanu, MM Constantin, A Zota, DM Dorobantu, T Constantin, ... Farmacia 64 (6), 2016 | 20 | 2016 |
| Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review P Bălănescu, A Lădaru, E Bălănescu, C Băicuş, GA Dan Biomarkers 19 (5), 345-355, 2014 | 18 | 2014 |
| Blood pressure patterns in patients with Parkinson’s disease: a systematic review D Tulbă, L Cozma, P Bălănescu, A Buzea, C Băicuș, BO Popescu Journal of personalized medicine 11 (2), 129, 2021 | 17 | 2021 |
| Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study A Bălănescu, P Bălănescu, V Comănici, I Stan, B Acs, L Prisăcariu, ... Romanian Journal of Internal Medicine 56 (1), 47-54, 2018 | 17 | 2018 |
| Surrogate markers of mucosal healing in inflammatory bowel disease: a systematic review M State, L Negreanu, T Voiosu, A Voiosu, P Balanescu, RB Mateescu World Journal of Gastroenterology 27 (16), 1828, 2021 | 16 | 2021 |
| Circulating Hsp90 isoform levels in overweight and obese children and the relation to nonalcoholic fatty liver disease: results from a cross-sectional study A Bălănescu, I Stan, I Codreanu, V Comănici, E Bălănescu, P Bălănescu Disease markers 2019, 2019 | 16 | 2019 |
| Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review A Constantin, D Năstase, D Tulbă, P Bălănescu, C Băicuș Lupus 29 (12), 1509-1519, 2020 | 12 | 2020 |
